Skip to main content
. 2022 May 4;198(2):307–316. doi: 10.1111/bjh.18214

FIGURE 3.

FIGURE 3

Kaplan–Meier survival estimates for the Castleman disease patients with a Certification and Access Subcommittee‐approved diagnosis in (A), the general Castleman disease cohort (n = 139) and (B), the idiopathic multicentric Castleman disease cohort (n = 71). CI, Confidence interval; KM, Kaplan–Meier